Publications by authors named "Baidi Lin"

Claim this Profile
E
Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients.
Jialun Han, Yi Zhang, Xiujin Shi, Baidi Lin, Yunnan Zhang, Jialin Yan, Yang Lin

Glob Heart· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Individualized Antiplatelet Therapy Based on Platelet Function Test in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.
Wenxing Peng, Yunnan Zhang, Baidi Lin, Yang Lin

J Cardiovasc Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin and the risk of neurodegenerative diseases in patients with diabetes: A meta-analysis of population-based cohort studies.
Yunnan Zhang, Yi Zhang, Xiujin Shi, Jialun Han, Baidi Lin, Yang Lin

Diabet Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.
Yunnan Zhang, Yi Zhang, Xiujin Shi, Baidi Lin, Jialun Han, Jialin Yan, Yang Lin

Thromb Haemost· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial.
Xiujin Shi, Yunnan Zhang, Yi Zhang, Ru Zhang, Baidi Lin, Jialin Yan, Yang Lin

Front Cardiovasc Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Danthron attenuates experimental atherosclerosis by targeting foam cell formation.
Xiujin Shi, Yi Zhang, Baidi Lin, Yang Zhou, Wei Suo, Lin Zhang, Jie Lin, Yang Lin

Exp Physiol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China.
Yi Zhang, Xiu-Jin Shi, Wen-Xing Peng, Jia-Lun Han, Bai-Di Lin, Jia-Lin Yan, Yang Lin

Front Pharmacol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis